SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-138095
Filing Date
2020-12-21
Accepted
2020-12-21 16:48:12
Documents
1
Period of Report
2020-12-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm2039008-2_4seq1.html 4  
1 FORM 4 tm2039008-2_4seq1.xml 4 3966
  Complete submission text file 0001104659-20-138095.txt   5468
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARQULE, INC. 1 WALL STREET, 6TH FLOOR BURLINGTON MA 01803
Business Address
SCHWARTZ BRIAN (Reporting) CIK: 0001431322 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 201404842